rfk glp-1 Heard on the Street: Jr. Is Spooking Obesity Investors Too RFK Jr speaks on weight
Description
Designed to complement your GLP-1 journey
adults will have obesity by 2035a burden that doesn't affect all races and ethnicities equally
Depression is a highly prevalent mood disorder and one of the major health concerns in modern society
The GLP-1 Receptor Agonist market size reached USD 15.25 Billion in 2024 and is expected to register a revenue CAGR of 21.7%
